Device performances and complications during hepatic arterial chemotherapy

G. Mondini, F. DeCian, N. Balletto, C. Spirito, R. Pellicci, M. Cosimelli, V. Quagliuolo, P. P. Cagol, D. Civalleri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The performances of totally implantable arterial infusion systems were compared in 135 patients with colorectal metastases undergoing intraarterial treatment. Seventy-eight patients received Fudr continuous infusion using either totally implantable pumps (group a = 44 pts) or ports fed by external portable pumps (group b = 34 pts) and 57 patients received bolus infusion of cisplatin (group c). Devices were cared for patency even after interruption of treatment, that was most commonly caused by disease progression. Pocket problems most frequently occurred in group a (30%) compared to groups b (9%) and c (7%) whereas a higher incidence of catheter and infusion related problems was observed in group b (109%) compared to groups a (27%) and c (32%). System failure was recorded as a cause of interruption of treatment in two, 9, and 6 cases in groups a to c, respectively. The 12-months device duration was 92% in group a, 24% in group b (median 9 months), and 65% in group c (median 17 months). Though implantable ports allow adequate infusion periods in most occasions they appear especially adequate for bolus infusions.

Original languageEnglish
Pages (from-to)168-172
Number of pages5
JournalRegional Cancer Treatment
Volume8
Issue number3-4
Publication statusPublished - 1995

Fingerprint

Drug Therapy
Equipment and Supplies
Liver
Cisplatin
Disease Progression
Therapeutics
Catheters
Neoplasm Metastasis
Incidence

Keywords

  • Implantable
  • Infusion pumps
  • Infusions intra-arterial
  • Liver neoplasms

ASJC Scopus subject areas

  • Oncology
  • Pharmacology

Cite this

Mondini, G., DeCian, F., Balletto, N., Spirito, C., Pellicci, R., Cosimelli, M., ... Civalleri, D. (1995). Device performances and complications during hepatic arterial chemotherapy. Regional Cancer Treatment, 8(3-4), 168-172.

Device performances and complications during hepatic arterial chemotherapy. / Mondini, G.; DeCian, F.; Balletto, N.; Spirito, C.; Pellicci, R.; Cosimelli, M.; Quagliuolo, V.; Cagol, P. P.; Civalleri, D.

In: Regional Cancer Treatment, Vol. 8, No. 3-4, 1995, p. 168-172.

Research output: Contribution to journalArticle

Mondini, G, DeCian, F, Balletto, N, Spirito, C, Pellicci, R, Cosimelli, M, Quagliuolo, V, Cagol, PP & Civalleri, D 1995, 'Device performances and complications during hepatic arterial chemotherapy', Regional Cancer Treatment, vol. 8, no. 3-4, pp. 168-172.
Mondini G, DeCian F, Balletto N, Spirito C, Pellicci R, Cosimelli M et al. Device performances and complications during hepatic arterial chemotherapy. Regional Cancer Treatment. 1995;8(3-4):168-172.
Mondini, G. ; DeCian, F. ; Balletto, N. ; Spirito, C. ; Pellicci, R. ; Cosimelli, M. ; Quagliuolo, V. ; Cagol, P. P. ; Civalleri, D. / Device performances and complications during hepatic arterial chemotherapy. In: Regional Cancer Treatment. 1995 ; Vol. 8, No. 3-4. pp. 168-172.
@article{05d2b29162194886976598c13f1504a7,
title = "Device performances and complications during hepatic arterial chemotherapy",
abstract = "The performances of totally implantable arterial infusion systems were compared in 135 patients with colorectal metastases undergoing intraarterial treatment. Seventy-eight patients received Fudr continuous infusion using either totally implantable pumps (group a = 44 pts) or ports fed by external portable pumps (group b = 34 pts) and 57 patients received bolus infusion of cisplatin (group c). Devices were cared for patency even after interruption of treatment, that was most commonly caused by disease progression. Pocket problems most frequently occurred in group a (30{\%}) compared to groups b (9{\%}) and c (7{\%}) whereas a higher incidence of catheter and infusion related problems was observed in group b (109{\%}) compared to groups a (27{\%}) and c (32{\%}). System failure was recorded as a cause of interruption of treatment in two, 9, and 6 cases in groups a to c, respectively. The 12-months device duration was 92{\%} in group a, 24{\%} in group b (median 9 months), and 65{\%} in group c (median 17 months). Though implantable ports allow adequate infusion periods in most occasions they appear especially adequate for bolus infusions.",
keywords = "Implantable, Infusion pumps, Infusions intra-arterial, Liver neoplasms",
author = "G. Mondini and F. DeCian and N. Balletto and C. Spirito and R. Pellicci and M. Cosimelli and V. Quagliuolo and Cagol, {P. P.} and D. Civalleri",
year = "1995",
language = "English",
volume = "8",
pages = "168--172",
journal = "Regional Cancer Treatment",
issn = "0935-0411",
publisher = "Springer Verlag",
number = "3-4",

}

TY - JOUR

T1 - Device performances and complications during hepatic arterial chemotherapy

AU - Mondini, G.

AU - DeCian, F.

AU - Balletto, N.

AU - Spirito, C.

AU - Pellicci, R.

AU - Cosimelli, M.

AU - Quagliuolo, V.

AU - Cagol, P. P.

AU - Civalleri, D.

PY - 1995

Y1 - 1995

N2 - The performances of totally implantable arterial infusion systems were compared in 135 patients with colorectal metastases undergoing intraarterial treatment. Seventy-eight patients received Fudr continuous infusion using either totally implantable pumps (group a = 44 pts) or ports fed by external portable pumps (group b = 34 pts) and 57 patients received bolus infusion of cisplatin (group c). Devices were cared for patency even after interruption of treatment, that was most commonly caused by disease progression. Pocket problems most frequently occurred in group a (30%) compared to groups b (9%) and c (7%) whereas a higher incidence of catheter and infusion related problems was observed in group b (109%) compared to groups a (27%) and c (32%). System failure was recorded as a cause of interruption of treatment in two, 9, and 6 cases in groups a to c, respectively. The 12-months device duration was 92% in group a, 24% in group b (median 9 months), and 65% in group c (median 17 months). Though implantable ports allow adequate infusion periods in most occasions they appear especially adequate for bolus infusions.

AB - The performances of totally implantable arterial infusion systems were compared in 135 patients with colorectal metastases undergoing intraarterial treatment. Seventy-eight patients received Fudr continuous infusion using either totally implantable pumps (group a = 44 pts) or ports fed by external portable pumps (group b = 34 pts) and 57 patients received bolus infusion of cisplatin (group c). Devices were cared for patency even after interruption of treatment, that was most commonly caused by disease progression. Pocket problems most frequently occurred in group a (30%) compared to groups b (9%) and c (7%) whereas a higher incidence of catheter and infusion related problems was observed in group b (109%) compared to groups a (27%) and c (32%). System failure was recorded as a cause of interruption of treatment in two, 9, and 6 cases in groups a to c, respectively. The 12-months device duration was 92% in group a, 24% in group b (median 9 months), and 65% in group c (median 17 months). Though implantable ports allow adequate infusion periods in most occasions they appear especially adequate for bolus infusions.

KW - Implantable

KW - Infusion pumps

KW - Infusions intra-arterial

KW - Liver neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0029554592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029554592&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 168

EP - 172

JO - Regional Cancer Treatment

JF - Regional Cancer Treatment

SN - 0935-0411

IS - 3-4

ER -